4.6 Article

Plasma enzymatic activity, proteomics and peptidomics in COVID-19-induced sepsis: A novel approach for the analysis of hemostasis

Related references

Note: Only part of the references are listed.
Article Emergency Medicine

Continuous enteral protease inhibition as a novel treatment for experimental trauma/hemorrhagic shock

Federico Aletti et al.

Summary: The study demonstrates that minimally invasive, continuous enteral protease inhibitor delivery improves outcomes in T/HS, with better arterial blood pressure and lactate levels in TXA-treated animals. Mass spectrometry analysis shows mitigation of systemic proteolysis in T/HS + TXA group. The findings suggest potential clinical translation of this approach for T/HS treatment.

EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY (2022)

Article Infectious Diseases

Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study

Carolina Garcia-Vidal et al.

Summary: The study found that co-infections and superinfections in hospitalized COVID-19 patients were relatively low compared to other viral pandemics. Patients experienced worse outcomes after hospital-acquired superinfections occurred.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Hematology

Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system

Maria Grazia Lazzaroni et al.

Summary: COVID-19 is a new pandemic caused by SARS-Cov2 infection, with inflammation and the innate immune system playing key roles in the most severe cases. Abnormalities in coagulation parameters and platelets count have been reported, suggesting a subgroup of patients with poor prognosis. The cytokine storm and virus-specific mechanisms may also contribute to adverse outcomes in COVID-19.

BLOOD REVIEWS (2021)

Article Biochemical Research Methods

Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology

Paige Haas et al.

Summary: The article discusses how proteomic research can investigate four key areas of SARS-CoV-2 biology through technologies, including solving structural issues through mass spectrometry, identifying virus-host protein-protein interactions, analyzing changes in signaling pathways during infection, and using proteomic technologies for biomarker identification and drug development.

JOURNAL OF PROTEOME RESEARCH (2021)

Article Critical Care Medicine

Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update

Waleed Alhazzani et al.

Summary: The Surviving Sepsis Campaign Coronavirus Disease 2019 panel issued nine statements on managing severe or critical coronavirus disease 2019 in the ICU, including recommendations for systemic corticosteroids and venous thromboprophylaxis while strongly advising against the use of hydroxychloroquine. The panel also made suggestions for the use of dexamethasone, remdesivir, convalescent plasma, and therapeutic anticoagulation, based on the available evidence.

CRITICAL CARE MEDICINE (2021)

Review Physiology

Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies

Miqueias Lopes-Pacheco et al.

Summary: SARS-CoV-2 is a novel coronavirus responsible for the COVID-19 pandemic, with the ability to infect human cells through binding to ACE2. This can lead to multi-organ dysfunction syndrome, highlighting the importance of understanding the virus's biology and pathogenesis for identifying effective therapies.

FRONTIERS IN PHYSIOLOGY (2021)

Letter Respiratory System

Between inflammation and thrombosis: endothelial cells in COVID-19

Anna Birnhuber et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

Review Critical Care Medicine

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

Marcin F. Osuchowski et al.

Summary: The zoonotic SARS-CoV-2 virus causing COVID-19 has devastating consequences worldwide, affecting primarily the respiratory system but also leading to long-term complications. Understanding the pathophysiology and immune response of COVID-19 is crucial for optimizing patient care and treatment strategies.

LANCET RESPIRATORY MEDICINE (2021)

Review Respiratory System

Current evidence for COVID-19 therapies: a systematic Literature review

Tobias Welte et al.

Summary: The systematic review of clinical trials on pharmacological interventions for COVID-19 highlighted the efficacy of interferons, remdesivir, and bromhexine when administered early. Lopinavir/ritonavir and hydroxychloroquine did not show significant efficacy, while dexamethasone significantly reduced mortality, hospitalization, and need for ventilation in severe cases. The review emphasized the importance of well-designed clinical trials and tailored interventions for optimal efficacy.

EUROPEAN RESPIRATORY REVIEW (2021)

Article Cell & Tissue Engineering

Digestive Enzyme Activity and Protein Degradation in Plasma of Heart Failure Patients

Vasiliki Courelli et al.

Summary: The study found that plasma trypsin levels were significantly elevated in heart failure patients, and were correlated with cardiac function and inflammatory markers. Mass spectrometry data showed an increased number of peptides in HF patients, originating from cleavage sites of trypsin and other degrading proteases.

CELLULAR AND MOLECULAR BIOENGINEERING (2021)

Review Biochemical Research Methods

Discovery Proteomics for COVID-19: Where We Are Now

Angela McArdle et al.

Summary: The study summarizes proteomic research on hallmark proteins associated with COVID-19, as well as the highly variable humoral response and increased risk of autoimmunity in the disease.

JOURNAL OF PROTEOME RESEARCH (2021)

Article Biochemistry & Molecular Biology

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev et al.

Summary: This study investigates the time-dependent progression of COIVD-19 inpatients by measuring diagnostic parameters and plasma proteomes, revealing an initial spike in inflammatory response followed by tissue repair and immunomodulation. Prognostic marker signatures for treatment strategies were identified and machine learning models based on proteome show transferability to independent cohorts.

CELL SYSTEMS (2021)

Review Critical Care Medicine

Sepsis: deriving biological meaning and clinical applications from high-dimensional data

Alex R. Schuurman et al.

Summary: The pathophysiology of sepsis is multifaceted and highly complex, with increased understanding vital for improving clinical care and outcomes. High-dimensional data analysis in various -omics fields is being used to unravel the complexity of sepsis, providing insights into the disease while also presenting challenges in deriving biological meaning and clinical applications.

INTENSIVE CARE MEDICINE EXPERIMENTAL (2021)

Review Hematology

COVID-19-associated coagulopathy and disseminated intravascular coagulation

Hidesaku Asakura et al.

Summary: The pathology of COVID-19 is exacerbated by thrombosis, DIC, and cytokine storms. D-dimer levels are commonly elevated in COVID-19, but relying solely on this marker has limitations. Treatment should be individualized based on disease severity and stage, with potential for combination therapy using heparin and nafamostat in the future. Further research is needed on fibrinolytic therapy and adsorption therapy.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)

Review Critical Care Medicine

SARS-COV-2/COVID-19: EVOLVING REALITY, GLOBAL RESPONSE, KNOWLEDGE GAPS, AND OPPORTUNITIES

Marcin F. Osuchowski et al.

SHOCK (2020)

Review Medicine, Research & Experimental

Rationale for targeting complement in COVID-19

Anastasia Polycarpou et al.

EMBO MOLECULAR MEDICINE (2020)

Review Immunology

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Yujun Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Biochemistry & Molecular Biology

Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection

Christoph B. Messner et al.

CELL SYSTEMS (2020)

Review Hematology

Coagulopathy in COVID-19

Toshiaki Iba et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Article Medicine, General & Internal

Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome

Marco Ranucci et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Letter Critical Care Medicine

VEGF-D: a novel biomarker for detection of COVID-19 progression

Yaxian Kong et al.

CRITICAL CARE (2020)

Article Anesthesiology

Proteolysis in septic shock patients: plasma peptidomic patterns are associated with mortality

J. Bauza-Martinez et al.

BRITISH JOURNAL OF ANAESTHESIA (2018)

Article Biochemical Research Methods

Peptigram: A Web-Based Application for Peptidomics Data Visualization

Jean Manguy et al.

JOURNAL OF PROTEOME RESEARCH (2017)

Article Critical Care Medicine

Peptidomic Analysis of Rat Plasma: Proteolysis in Hemorrhagic Shock

Federico Aletti et al.

SHOCK (2016)

Article Emergency Medicine

ShockOmics: multiscale approach to the identification of molecular biomarkers in acute heart failure induced by shock

Federico Aletti et al.

SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE (2016)